Shreshta Tripathi Profile
Shreshta Tripathi

@ShreshtaT

Followers
242
Following
677
Media
26
Statuses
436

MD Internal Medicine, DM Nephrology-in training #NephEdC @NSMCInternship

Mumbai
Joined October 2014
Don't wanna be here? Send us removal request.
@ShreshtaT
Shreshta Tripathi
1 year
Happy to share my *first ever* Visual Abstract!! .All thanks to my amazing mentors at @NSMCInternship!. Reference article:
Tweet media one
1
6
45
@ShreshtaT
Shreshta Tripathi
1 year
RT @NephJC: What's the ideal BP target? Critiques of the SPRINT trial long chanted the limitations, which echoed even in some of the guidel….
Tweet card summary image
nephjc.com
This week, we will discuss the ongoing saga of blood pressure targets in patients with hypertension. This time its ESPRIT (Effects of Intensive Systolic Blood Pressure Lowering Treatment in Reducing...
0
16
0
@ShreshtaT
Shreshta Tripathi
1 year
RT @edgarvlermamd: Hypokalemia and alkalosis syndromes (and Gordon syndrome) from @RenalFellowNtwk #Nephpearls #HTNSecrets . Credit: Anthon….
0
79
0
@ShreshtaT
Shreshta Tripathi
1 year
RT @Neph_SIM: "What's in a Fibril?" #Nephrology #FOAMed .
Tweet media one
0
24
0
@ShreshtaT
Shreshta Tripathi
1 year
RT @divyamittal_IAS: Just keep showing up and you will become unstoppable. Consistency is the single most important ingredient of success.….
0
219
0
@ShreshtaT
Shreshta Tripathi
1 year
RT @kidney_boy: Hypernatremia, intensivists vs nephrologists
0
79
0
@ShreshtaT
Shreshta Tripathi
1 year
RT @NephroP: July series: Recap for new #ICU / #Nephrology fellows - Basic cardiac views .#FOAMed #FOAMcc #Nephpearls.Image courtesy: Phili….
0
345
0
@ShreshtaT
Shreshta Tripathi
1 year
RT @divyamittal_IAS: Hard work is not when you are motivated enough. It's when you continue even when you are feeling demotivated.
0
279
0
@ShreshtaT
Shreshta Tripathi
1 year
RT @rheault_m: Not all renal disease with deafness is #Alport syndrome. Couldn't find a comprehensive table, so I made one myself. #nephpea….
0
202
0
@ShreshtaT
Shreshta Tripathi
1 year
RT @SantamariaFcoMD: Hello everyone! Today we will discuss CKD of Uncertain Etiology (CKDu) and the biomarkers that we have for its evaluat….
0
13
0
@ShreshtaT
Shreshta Tripathi
1 year
RT @NephJC: T2j:.Median eGFR at diagnosis:.⏫Highest- Gitelman 106.Thin basement membrane 97, .Tuberous sclerosis 95.⏬Lowest- Anti-GBM 11, A….
0
2
0
@ShreshtaT
Shreshta Tripathi
1 year
RT @NephJC: T1g:.10 rare diseases (included in the registry) were excluded from this study because of either a small sample size (< 85 pati….
0
4
0
@ShreshtaT
Shreshta Tripathi
1 year
RT @NephJC: And since we loved this study, we couldn't have just a single #visualabstract #nephjc. Same RaDaR study, but a more colorful pe….
0
7
0
@ShreshtaT
Shreshta Tripathi
1 year
RT @NephJC: Look at the beautiful visual abstract made by @Brian_rifkin 🎨.#NephJC .
Tweet media one
0
6
0
@ShreshtaT
Shreshta Tripathi
1 year
RT @edgarvlermamd: MT @jbcarmody How much Na 🧂 is in ….#Nephpearls
Tweet media one
0
181
0
@ShreshtaT
Shreshta Tripathi
1 year
RT @eddyjoemd: The truth is that you’ll never actually “make it”. Once you hit your goal you’ll immediately formulate another one. The driv….
0
50
0
@ShreshtaT
Shreshta Tripathi
1 year
RT @JasmineNephro: Diuretic braking😞-leads to diuretic resistance . 🅰️Braking-Chronic loop diuretic-Ang/aldosterone⬆️-⬆️Na reabsorb in DCT….
0
64
0
@ShreshtaT
Shreshta Tripathi
1 year
RT @priti899: 📢Exciting times in the treatment of Membranous Nephropathy!💥💥. ☄️Discover the latest 🛸 breakthroughs and new drugs driving a….
0
49
0
@ShreshtaT
Shreshta Tripathi
1 year
RT @Sthanu5: Some pearls in Urology.
Tweet media one
0
39
0
@ShreshtaT
Shreshta Tripathi
1 year
RT @acagamic: A research paper overview in a lo-fi mindmap
Tweet media one
0
137
0
@ShreshtaT
Shreshta Tripathi
1 year
RT @NephroSeeker: 📚Looking through abstracts presented at #ERA24, published in @NDTsocial. 🧵Found lots of interesting stuff 👇 https://t.co/….
0
14
0